• 25-Hydroxycholesterol Drives Immunosuppressive Macrophage Me

  2026-04-29

  Xiao et al. (2024) uncover a lysosomal 25-hydroxycholesterol (25HC)–AMPK axis that metabolically reprograms tumor-associated macrophages (TAMs) toward immunosuppression. By detailing how CH25H-derived 25HC activates AMPKα and STAT6 signaling, the study presents a mechanistic basis for targeting macrophage metabolism to enhance anti-tumor immunity.

• Pentoxifylline Modulates Neonatal Monocyte Hyperinflammation

  2026-04-28

  This study investigates how pentoxifylline (PTX) modulates LPS-induced hyperinflammation in monocytes from preterm infants, revealing strong anti-inflammatory effects via downregulation of TLR4 and key surface markers. Findings highlight age-dependent immune responses and provide a mechanistic basis for PTX's adjunctive use in neonatal sepsis, with implications for pathway-targeted modulation strategies.

• Crizotinib Hydrochloride in Next-Generation Precision Oncolo

  2026-04-28

  Explore how Crizotinib hydrochloride, a potent ALK kinase inhibitor, advances precision oncology by enabling nuanced studies of tumor–stroma interactions and drug resistance using sophisticated assembloid models. This article delivers new insights for optimizing cancer biology research workflows.

• Mapping Metabolite Regulation of TET2 via Biochemical and NM

  2026-04-27

  Zhang et al. present a robust protocol integrating biochemical assays and saturation transfer difference (STD) NMR spectroscopy to quantify metabolite binding and regulatory effects on TET2 dioxygenase. This approach enables precise identification of endogenous TET2 modulators, offering new mechanistic insight into the metabolic-epigenetic interface and supporting reproducible discovery of activators and inhibitors.

• Applied Workflows with 3-Deazaneplanocin (DZNep) in Cancer R

  2026-04-27

  3-Deazaneplanocin (DZNep) from APExBIO empowers precision-targeted epigenetic modulation for cancer and metabolic disease studies, enabling robust protocols for apoptosis induction and cancer stem cell targeting. This guide translates current research, including breast cancer heterogeneity insights, into actionable workflow enhancements and troubleshooting strategies.

• Flavopiridol: Strategic Insights for Translational Cell Cycl

  2026-04-26

  This article delivers a thought-leadership perspective on leveraging Flavopiridol as a pan-CDK inhibitor in translational research, integrating mechanistic understanding, protocol optimization, and future directions for cancer and stem cell models. Emphasizing both biological rationale and workflow practicality, it uniquely bridges ER stress with cell cycle regulation, setting a new standard for experimental design and data reproducibility in the field.

• miR-18a/ALOXE3 Axis: Ferroptosis and Migration in Glioblasto

  2026-04-25

  Yang et al. (2021) reveal that miR-18a enhances glioblastoma progression by downregulating ALOXE3, which suppresses ferroptosis and promotes migration via altered lipid signaling. These insights position the miR-18a/ALOXE3 pathway as a potential therapeutic target and clarify the mechanistic interplay between lipid metabolism and GPCR-mediated cell signaling in GBM.

• EGTA (Egtazic Acid): Precision Calcium Chelation in Cardiac-

  2026-04-24

  Explore the unique role of EGTA (egtazic acid) as a selective calcium chelator in dissecting cardiac vagal neuron pathways and presynaptic/postynaptic signaling. This article offers a deeper, application-focused analysis, leveraging breakthrough insights from electrophysiology and molecular pharmacology.

• Rhodamine B: Next-Gen Tracer for Translational Drift Studies

  2026-04-24

  This article explores Rhodamine B’s pivotal role in bridging environmental monitoring and advanced cellular analysis. Integrating mechanistic insight and translational strategy, it highlights how Rhodamine B’s solubility, purity, and fluorescence properties empower researchers to achieve reproducible drift assessment and cell-based assay innovation. The narrative leverages recent comparative UAV/EKS field studies, critically appraises current methodologies, and provides actionable protocol guidance for translational researchers.

• Plerixafor (AMD3100): Advanced Insights for Cancer and Stem

  2026-04-23

  Discover how Plerixafor (AMD3100) empowers cancer metastasis inhibition and hematopoietic stem cell mobilization through CXCR4 antagonism. This in-depth article uniquely analyzes the latest mechanistic findings and practical assay guidance for translational research.

• Latrunculin B: Strategic Actin Disruption for Translational

  2026-04-23

  Explore how Latrunculin B’s precise, transient inhibition of actin polymerization underpins next-generation cytoskeletal research and translational innovation. This article bridges mechanistic insight with experimental strategy, contextualizing the compound’s capabilities and boundaries via recent peer-reviewed evidence and advanced workflows. APExBIO’s Latrunculin B (C5804) is spotlighted for its purity, reproducibility, and unique suitability for short-duration cellular actin dynamics studies.

• 12-O-tetradecanoyl phorbol-13-acetate: Optimizing ERK/MAPK A

  2026-04-22

  Harness the full potential of 12-O-tetradecanoyl phorbol-13-acetate (TPA) for precise ERK/MAPK pathway activation and advanced signal transduction research. This guide offers actionable protocols, troubleshooting insights, and context from recent studies to empower reproducible kinase assays and disease modeling.

• CARD8 Inflammasome Activation Drives Pyroptosis in Human T C

  2026-04-22

  This study reveals that inhibiting dipeptidyl-peptidases in human T cells activates the CARD8 inflammasome, leading to pyroptotic cell death via the CARD8-caspase-1-GSDMD axis. These findings extend the role of inflammasome signaling and regulated pyroptosis beyond myeloid cells into the adaptive immune system, providing mechanistic insight relevant to immunomodulatory research and tumor microenvironment studies.

• Mechanisms of ZAK Activation at Collided Ribosomes Revealed

  2026-04-21

  This study uncovers the molecular events underlying the activation of MAP3K ZAK at collided ribosomes, clarifying the structural and biochemical basis for ribotoxic stress signaling. The findings provide a blueprint for studying kinase-driven stress responses and inform advanced applications in translational models of kinase signaling.

• Axitinib (AG 013736): Quantitative Insights for Advanced VEG

  2026-04-21

  Explore the unique quantitative applications of Axitinib (AG 013736) for dissecting VEGF signaling and angiogenesis inhibition in cancer biology research. This article reveals how precise response metrics reshape experimental design, setting it apart from existing guides.

407 records 17/28 page Previous Next First page 上5页 1617181920 下5页 Last page